Boston Properties Inc. (0HOX)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 61.10 |
|---|---|
| 52-week range | 49.77 – 74.71 |
| Return, 1 month / 3 months | −0.8% / −10.3% |
| Return, 1 year / 3 years | −13.5% / +35.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 51 |
| Volatility (1 year) | 29.5% |
| Worst drawdown (1 year) | -30.4% |
| Average daily value traded | 0.01M USD |
| Dividend yield | 4.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Boston Properties is a real estate investment trust that owns, operates and develops office buildings, mainly in major American cities. Its portfolio centres on workplaces leased to corporate, professional and government tenants, and the company also takes on development and redevelopment projects. It manages its properties directly and collects rent from the businesses that occupy its buildings. The company is based in the United States and concentrates on large urban office markets rather than retail or industrial property.
On this site Boston Properties Inc. appears as a stock on the London Stock Exchange (UK), code 0HOX, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Boston Properties Inc. (0HOX) trades on the London Stock Exchange in UK. It last closed at USD 61.10 on 27 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 2,259 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.5% and over the last three months it fell 10.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.1% | ||
| From 52-week high | -18.2% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.3% | ||
| 6-month return | 7.1% | ||
| 12-month return, skipping the last month | -12.9% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.4% | ||
| Liquidity | 14 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 78 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.6% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +3.3% |
|---|---|
| 1 month | −0.8% |
| 3 months | −10.3% |
| 6 months | +7.1% |
| 1 year | −13.5% |
| 3 years | +35.9% |
| 5 years | −31.7% |
Signals
| 50-day / 200-day average | 63.02 / 61.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 1.68 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Sep 2026 | USD 0.7000 |
| 30 Jun 2026 | USD 0.7000 |
| 30 Mar 2026 | USD 0.7000 |
| 30 Dec 2025 | USD 0.7000 |
| 29 Sep 2025 | USD 0.7000 |
| 30 Jun 2025 | USD 0.9800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.